PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jul-2022 Tetra Therapeutics Initiates Phase 2b/3 Clinical Studies of Investigational Drug BPN14770 in Fragile X Syndrome Businesswire
12-Jul-2022 Propanc Biopharma’s CEO Believes Lead Asset Could Unlock Value as PRP Advances to Phase I, First-In-Human Study in Advanced Cancer Patients Businesswire
12-Jul-2022 Happify Health Weaves a New Path as Twill, the Intelligent Healing Company™ Businesswire
12-Jul-2022 Saphetor Partners With PTC Therapeutics to Advance Awareness of Clinical Programs in Rare Diseases Businesswire
12-Jul-2022 Evolus Successfully Completes Patient Enrollment in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau® Businesswire
12-Jul-2022 Insights on the Protein Purification & Isolation Global Market to 2027 - Players Include Abcam, Agilent Technologies and BioAstrum - ResearchAndMarkets.com Businesswire
12-Jul-2022 NanoVibronix Announces Webinar Series to Promote UroShield Businesswire
12-Jul-2022 Charles River Associates’ (CRA) Global Life Sciences Practice Launches Data Analytics Platform Businesswire
12-Jul-2022 Matter Opens Dallas Office to Support the Region’s Booming Healthcare + Tech Presence Businesswire
12-Jul-2022 Worldwide Clinical Trials Enters Into a Strategic Collaboration With Invitae to Accelerate Clinical Trials for Rare Disease Patients Businesswire
12-Jul-2022 Sampled Appoints Sarah Hersey, VP, Head of Translational Sciences & Diagnostics at Bristol Myers Squibb, as its First Independent Director Businesswire
12-Jul-2022 VitalSource Now Carries Complete Labster Portfolio of Science Lab Simulations Businesswire
12-Jul-2022 Histopathology Data of Preclinical Repeated Dose Toxicity Study and ex vivo Human Tissue Cross-Reactivity (TCR) Analysis Support Safety of IPA’s PolyTope® TATX-03, a Synergistic Antibody Cocktail against SARS‑CoV‑2 Businesswire
12-Jul-2022 Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy Newswire
12-Jul-2022 Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restoration System Businesswire
12-Jul-2022 Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder Businesswire
12-Jul-2022 Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target Businesswire
12-Jul-2022 Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors Businesswire
12-Jul-2022 ATCC Expands Leadership Team to Provide Vision and Growth Strategy Businesswire
12-Jul-2022 Hildred Capital Management Promotes Kevin Regan to Vice President Businesswire